EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Iron Metabolism and Ferroptosis as Novel Therapeutic Approaches in Cardiovascular Diseases

Yufei Chen, Xueting Li, Siyuan Wang, Ran Miao, Jiuchang Zhong iD

Nutrients · 23.01.2023 · 15 (3) · 591

DOI: 10.3390/nu15030591 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 23.01.2023. Verfasst von Yufei Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China. Hauptthemen laut MEDLINE: Ferroptosis, Cardiovascular Diseases, Myocardial Reperfusion Injury, Hypertension. Die Arbeit wurde bisher 129-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Program and the National Major Research Plan Training Program of the National Nat-ural Science Foundation of China, Beijing Natural Science Foundation, Clinical Research Incubation Program of Beijing Chaoyang Hospital Affiliated to Capital Medi-cal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Iron functions as an essential micronutrient and participates in normal physiological and biochemical processes in the cardiovascular system. Ferroptosis is a novel type of iron-dependent cell death driven by iron accumulation and lipid peroxidation, characterized by depletion of glutathione and suppression of glutathione peroxidase 4 (GPX4). Dysregulation of iron metabolism and ferroptosis have been implicated in the occurrence and development of cardiovascular diseases (CVDs), including hypertension, atherosclerosis, pulmonary hypertension, myocardial ischemia/reperfusion injury, cardiomyopathy, and heart failure. Iron chelators deferoxamine and dexrazoxane, and lipophilic antioxidants ferrostatin-1 and liproxstatin-1 have been revealed to abolish ferroptosis and suppress lipid peroxidation in atherosclerosis, cardiomyopathy, hypertension, and other CVDs. Notably, inhibition of ferroptosis by ferrostatin-1 has been demonstrated to alleviate cardiac impairments, fibrosis and pathological remodeling during hypertension by potentiating GPX4 signaling. Administration of deferoxamine improved myocardial ischemia/reperfusion injury by inhibiting lipid peroxidation. Several novel small molecules may be effective in the treatment of ferroptosis-mediated CVDs. In this article, we summarize the regulatory roles and underlying mechanisms of iron metabolism dysregulation and ferroptosis in the occurrence and development of CVDs. Targeting iron metabolism and ferroptosis are potential therapeutic strategies in the prevention and treatment of hypertension and other CVDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisCardiovascular DiseasesMyocardial Reperfusion InjuryHypertensionHumansDeferoxamineLipid PeroxidationIronCyclohexylaminesPhenylenediamines

Stichwörter der Autor:innen

cardiovascular diseasesferroptosisiron chelatoriron metabolismlipid peroxidation

Substanzen

DeferoxamineIronferrostatin-1CyclohexylaminesPhenylenediamines

Autor:innen und Institutionen

  • Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
  • Department of Cardiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
  • Medical Research Center, Beijing Institute of Respiratory Medicine and Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.

ORCID-Profile: Jiuchang Zhong

Förderung

  • General Program and the National Major Research Plan Training Program of the National Nat-ural Science Foundation of China
  • Beijing Natural Science Foundation
  • Clinical Research Incubation Program of Beijing Chaoyang Hospital Affiliated to Capital Medi-cal University
  • Reform and Development Program of Beijing Institute of Respiratory Medicine
  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing
  • Beijing Chaoyang Hospital Affiliated to Capital Medical University
  • Beijing Institute of Respiratory Medicine

Zitieren

APA

Chen, Y., Li, X., Wang, S., Miao, R., & Zhong, J. (2023). Targeting Iron Metabolism and Ferroptosis as Novel Therapeutic Approaches in Cardiovascular Diseases. Nutrients, 15(3), 591. https://doi.org/10.3390/nu15030591

Vancouver

Chen Y, Li X, Wang S, Miao R, Zhong J. Targeting Iron Metabolism and Ferroptosis as Novel Therapeutic Approaches in Cardiovascular Diseases. Nutrients. 2023;15(3):591. doi:10.3390/nu15030591

BibTeX
@article{Chen2023,
  author = {Chen, Yufei and Li, Xueting and Wang, Siyuan and Miao, Ran and Zhong, Jiuchang},
  title = {Targeting Iron Metabolism and Ferroptosis as Novel Therapeutic Approaches in Cardiovascular Diseases},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {591},
  doi = {10.3390/nu15030591}
}
Kostenlos starten →